27
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Identifying a new marker and potential therapeutic target in mantle cell lymphoma: Cutting to the chase

, MD
Pages 1236-1237 | Published online: 01 Jul 2009

References

  • Drucker B J. Perspectives on the development of a molecularly targeted agent. Cancer Cell 2002; 1: 31–36
  • Thieblemont C, Rolland D, Baseggio L, Felman P, Gazzo S, Callet-Bauchu E, et al. Comprehensive analysis of GST-π expression in B-cell lymphomas: correlation with histological subtypes and survival. Leukemia Lymphoma, in press
  • Thieblemont C, Nassar V, Felman P, Leroy K, Gazzo S, Callet-Bauchu E, et al. Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis. Blood 2004; 103: 2727–2737
  • Tew K. Glutathione-associated enzymes in the anticancer drug resistance. Cancer Res 1994; 54: 4323–4320
  • Fu K, Weisenburger D, Greiner T, Dave S, Wright G, Rosenwald A, et al. CyclihnD1-negative mantle cell lymphoma: a clinicopathological study based on gene expression profiling. Blood 2005; 106: 4315–4321

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.